U.S. Chemicals Stock News

Cardinal Health (CAH) is back in focus after expanding Actinium-225 production at its Center for Theranostics Advancement in Indianapolis. This move is aimed at supplying more material for investigational and future commercial cancer therapies. See our latest analysis for Cardinal Health. Recent news around Actinium-225 expansion and a board leadership change comes as Cardinal Health’s share price sits at US$214.05, with a 1-year share price return and a very large 5-year total shareholder...

Parker-Hannifin recently reported record quarterly sales and earnings that exceeded analyst expectations, while outlining plans to acquire Filtration Group Corporation and integrate it over the next six to twelve months. This combination of stronger-than-expected operational performance and an expansion into complementary filtration technologies could meaningfully influence Parker-Hannifin’s long-term business mix and earnings profile. With this backdrop, we’ll now explore how the Filtration...

In March 2026, Semtech announced the TDS5311P, a new SurgeSwitch circuit protection device that delivers near-constant clamping voltage for 48 V USB Power Delivery Extended Power Range systems in industrial, rugged mobility, and high-performance portable applications. By directly addressing designers’ protection gap in higher-voltage USB PD EPR systems with a compact, surge-rated FET architecture, Semtech is sharpening its position in power management solutions for emerging industrial and...

Ameresco stock at a glance Ameresco (AMRC) has drawn investor attention after its recent share performance, with a one-month return showing about a 4% decline and a three-month return showing nearly a 20% decline, alongside revenue of US$1.93b and net income of US$44.18m. See our latest analysis for Ameresco. After a sharp 1 year total shareholder return of about 127%, recent share price returns have cooled, with a 7 day share price return of about an 8% decline and a 90 day share price...

In the past week, Pathward Financial drew attention after analysts highlighted its history of surpassing earnings estimates and its current positive Earnings ESP combined with a solid Zacks Rank. A key insight is that growing analyst optimism, grounded in recent earnings outperformance, is emerging as an important driver of sentiment around the bank’s upcoming results. Next, we’ll explore how this increased analyst confidence in Pathward’s earnings prospects could influence its existing...

Expedia Group (EXPE) is back in focus after Jefferies shifted its view to a Buy rating, highlighting the company’s B2B growth, AI and machine learning investments, and capital returns through dividends and share repurchases. See our latest analysis for Expedia Group. Even with Jefferies’ upgrade and recent commentary pointing to double digit bookings growth and AI driven product improvements, Expedia Group’s 30 day share price return of 9.74% and year to date share price return of 20.37%...

Atlantic Union Bankshares (AUB) has attracted interest after recent share price moves, with the stock closing at $36.09. Investors are weighing its valuation, profitability, and recent return profile across different time periods. See our latest analysis for Atlantic Union Bankshares. While the latest share price of $36.09 comes after a 7 day share price return of 3.74%, the longer picture is driven more by income and dividends, with a 1 year total shareholder return of 47.77% and a 3 year...

Why the Lefay joint venture matters for Marriott International (MAR) The newly announced joint venture with Lefay puts Marriott International (MAR) directly into luxury wellness hospitality, giving the group its first brand focused solely on holistic wellbeing and eco-resorts. This move connects Lefay's wellness philosophy and Italian resort portfolio with Marriott's Marriott Bonvoy platform and development capabilities. It is a combination that could influence how investors think about the...

Pinnacle West Capital (PNW) has drawn fresh attention after recent trading left the share price at $102.70. This has put a spotlight on how its Arizona focused regulated electricity business lines up with recent return trends. See our latest analysis for Pinnacle West Capital. The recent 1-day share price return of 1.15% and 7-day share price return of 3.02% sit alongside a 90-day share price return of 17.10%. The 1-year total shareholder return of 17.30% and 5-year total shareholder return...

In late April 2026, Ventas, Inc. released its first‑quarter 2026 results and hosted an investor conference call with webcast and replay access following the close of New York Stock Exchange trading. At the same time, Baron Capital’s Baron Real Estate Income Fund increased its Ventas holdings, underscoring institutional confidence in the company’s senior housing focus and an external growth pipeline expected to exceed US$2.50 billion in 2026. We’ll now examine how this increased institutional...

Why Prologis Stock Is Back in Focus Prologis (PLD) is drawing fresh attention after amending its global credit facilities to secure up to US$3b in revolving, multicurrency capacity. Earnings estimate upgrades and rating changes are also building interest ahead of the April 16 report. See our latest analysis for Prologis. The stock has been relatively steady over the past month, but a 3.78% 7 day share price return and a 40.91% 1 year total shareholder return indicate that momentum has been...

Viper Energy recently reported year-over-year revenue growth that outpaced peers and topped analyst expectations, supported by successful integration of newly acquired mineral and royalty assets in the Permian Basin. At the same time, stronger crude and natural gas liquids pricing, together with Viper’s capital‑light royalty model, has amplified the earnings impact of its expanded portfolio. With that backdrop, we’ll now consider how stronger-than-expected revenue performance under higher...

TransUnion (TRU) has rolled out TruIQ Credit Strategy Studio and expanded its relationship with MRI-Simmons, giving lender and advertiser clients new tools to design, test and activate campaigns within unified data and workflow environments. See our latest analysis for TransUnion. These launches and partnerships come as TransUnion’s share price trades at US$69.32, with a 7 day share price return of 5.41% after a weaker 30 day and 90 day stretch. The 3 year total shareholder return of 14.72%...

V2X, Inc. recently appointed Mike Uster as Chief Information Officer, tasking him with leading global IT strategy, cybersecurity, and AI-enabled digital transformation to support the company’s mission-critical defense operations. Uster’s long track record implementing zero-trust architectures and AI-driven capabilities for government and defense clients could materially influence how V2X modernizes its technology backbone for complex contracts worldwide. We’ll now examine how Uster’s...

Erie Indemnity (ERIE) is back in focus as investors look ahead to its upcoming fiscal Q1 2026 earnings, following weaker Q4 2025 results and a mixed track record against recent quarterly expectations. See our latest analysis for Erie Indemnity. The upcoming Q1 2026 release comes after a weak Q4 and a clear loss of momentum, with a 90 day share price return decline of 11.5% and a 1 year total shareholder return loss of 36%, even though the stock has bounced 3.6% over the past week to...

Recent analyst commentary around HCA Healthcare (HCA) has centered on its 2026 guidance, connecting executive incentive plans, hospital expansion projects, artificial intelligence tools, and new service lines that some investors view as important potential growth drivers. See our latest analysis for HCA Healthcare. The recent 11.4% 1 month share price decline to around $471.84 comes after a strong 1 year total shareholder return of 43.2%. This suggests shorter term momentum has cooled even as...

In March 2026, Element Solutions Inc. reported that Executive Chairman Sir Martin E. Franklin would step down and not seek re-election at the 2026 Annual Meeting, with long-time director Ian G.H. Ashken set to become Non-Executive Chairman. Around the same time, high-profile commentary from Jim Cramer spotlighted Element Solutions’ growth outlook and valuation in specialty chemicals, bringing renewed attention to its role in advanced electronics and semiconductor markets. With Jim Cramer...

T. Rowe Price Group (TROW) has appointed Bill Cashel as Head of Alternatives for U.S. Wealth, a move focused on expanding its alternative and private market offering for retirement and wealth investors. See our latest analysis for T. Rowe Price Group. The appointment of a dedicated alternatives head comes as T. Rowe Price Group’s share price has eased in recent months, with a 90-day share price return of a 15.33% decline and a year-to-date share price return of a 13.82% decline, while the...

In recent weeks, BKV Corporation has drawn fresh attention as Jim Cramer highlighted its natural gas, power generation and carbon capture businesses against a backdrop of shifting Middle East geopolitics and rising focus on U.S. LNG exports. At the same time, revised analyst earnings expectations and BKV’s push to lock in long-term power contracts at its Temple Energy Complex underscore how investor debate is increasingly centered on the durability and visibility of its future cash...

In late March and early April 2026, Applied Optoelectronics Inc. announced that a major hyperscale customer expanded its 800G single‑mode data center transceiver orders to US$124 million, while earlier also securing an over US$200 million volume order for 1.6T modules and beginning initial 800G shipments to a second hyperscale client. Together, these large AI‑oriented transceiver commitments significantly increase Applied Optoelectronics’ backlog and highlight how its vertically integrated...

Spyre Therapeutics (SYRE) recently accelerated its Phase 2 SKYWAY basket trial by completing enrollment for the rheumatoid arthritis sub study of SPY072 ahead of schedule, with topline data now guided for Q3 2026. See our latest analysis for Spyre Therapeutics. The accelerated SKYWAY timeline comes on top of a sharp run, with Spyre Therapeutics posting a 30 day share price return of 18.51% and a 90 day share price return of 58.81%. The 1 year total shareholder return of 272.01% and 3 year...

AZZ (AZZ) is back on investors’ radar after better than expected Q3 2026 earnings and revenue, fresh fiscal 2027 guidance, a new US$100 million buyback plan, and recent institutional buying interest. See our latest analysis for AZZ. AZZ’s share price has climbed 13.87% over the past 90 days and its 1 year total shareholder return of 65.39% and 3 year total shareholder return above 200% point to strong momentum around recent earnings beats, fiscal 2027 guidance, buybacks, and fresh...

FuboTV (NYSE:FUBO) approved a reverse stock split and amended its bylaws to reflect the change. The reverse split has already been implemented, consolidating existing shares into a smaller number. These actions adjust the company’s share structure and may influence its exchange listing status and future financing options. FuboTV operates a live TV streaming platform focused on sports, news, and entertainment, positioning itself as an alternative to traditional cable bundles. The reverse...

Green Brick Partners, Inc. and HFI Capital Management, LLC have launched Rainwater Crossing, a master-planned community in Celina, Texas, with Phase One builders Normandy Homes and Centre Living Homes, extensive amenities, and public art, following its spring 2026 debut plan. The emphasis on art-driven placemaking and a broad amenity mix, including over six miles of trails and multiple future amenity sites, highlights Green Brick’s focus on lifestyle communities that could influence how...